BioNexus Gene Lab BGLC Stock
BioNexus Gene Lab Price Chart
BioNexus Gene Lab BGLC Financial and Trading Overview
| BioNexus Gene Lab stock price | 0.63 USD |
| Previous Close | 0.28 USD |
| Open | 0.23 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.28 - 0.28 USD |
| 52 Week Range | 0.08 - 1.21 USD |
| Volume | 117 USD |
| Avg. Volume | 6.31K USD |
| Market Cap | 48.12M USD |
| Beta (5Y Monthly) | 0.751972 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.27 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BGLC Valuation Measures
| Enterprise Value | 46.2M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.6823044 |
| Price/Book (mrq) | 7.289474 |
| Enterprise Value/Revenue | 4.495 |
| Enterprise Value/EBITDA | -161.264 |
Trading Information
BioNexus Gene Lab Stock Price History
| Beta (5Y Monthly) | 0.751972 |
| 52-Week Change | -77.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.21 USD |
| 52 Week Low | 0.08 USD |
| 50-Day Moving Average | 0.35 USD |
| 200-Day Moving Average | 0.79 USD |
BGLC Share Statistics
| Avg. Volume (3 month) | 6.31K USD |
| Avg. Daily Volume (10-Days) | 4.5K USD |
| Shares Outstanding | 173.72M |
| Float | 81.38M |
| Short Ratio | N/A |
| % Held by Insiders | 64.67% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -4.30% |
| Operating Margin (ttm) | -3.66% |
| Gross Margin | 12.37% |
| EBITDA Margin | -2.78% |
Management Effectiveness
| Return on Assets (ttm) | -2.71% |
| Return on Equity (ttm) | -6.46% |
Income Statement
| Revenue (ttm) | 10.28M USD |
| Revenue Per Share (ttm) | 0.06 USD |
| Quarterly Revenue Growth (yoy) | -21.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -286482 USD |
| Net Income Avi to Common (ttm) | -442098 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.97M USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 52.41K USD |
| Total Debt/Equity (mrq) | 0.8 USD |
| Current Ratio (mrq) | 3.492 |
| Book Value Per Share (mrq) | 0.038 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 463.57K USD |
| Levered Free Cash Flow (ttm) | 709.6K USD |
Profile of BioNexus Gene Lab
| Country | United States |
| State | N/A |
| City | Kuala Lumpur |
| Address | Tower B, Vertical Business Suite |
| ZIP | 59200 |
| Phone | 60 1 2212 6512 |
| Website | https://www.bionexusgenelab.com |
| Industry | Specialty Chemicals |
| Sector(s) | Basic Materials |
| Full Time Employees | 27 |
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Q&A For BioNexus Gene Lab Stock
What is a current BGLC stock price?
BioNexus Gene Lab BGLC stock price today per share is 0.63 USD.
How to purchase BioNexus Gene Lab stock?
You can buy BGLC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioNexus Gene Lab?
The stock symbol or ticker of BioNexus Gene Lab is BGLC.
Which industry does the BioNexus Gene Lab company belong to?
The BioNexus Gene Lab industry is Specialty Chemicals.
How many shares does BioNexus Gene Lab have in circulation?
The max supply of BioNexus Gene Lab shares is 18.72M.
What is BioNexus Gene Lab Price to Earnings Ratio (PE Ratio)?
BioNexus Gene Lab PE Ratio is now.
What was BioNexus Gene Lab earnings per share over the trailing 12 months (TTM)?
BioNexus Gene Lab EPS is -0.27 USD over the trailing 12 months.
Which sector does the BioNexus Gene Lab company belong to?
The BioNexus Gene Lab sector is Basic Materials.
BioNexus Gene Lab BGLC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
- {{ link.label }} {{link}}